• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Sjögren’s Center

Show Search
Hide Search
  • Sjögren’s Syndrome Information
    • Diagnosis of Sjögren’s Syndrome
    • Sjögren’s Syndrome Symptoms
    • Treatment of Sjögren’s Syndrome
    • Sjögren’s Syndrome Disease Education Series
  • About the Center
    • Meet Our Team
    • Schedule An Appointment
    • Physician Referral Information
    • Directions
  • Research
  • Support the Center
  • Contact Us
Home / Research

Research

Clinical Trials

  • A randomized, double-blind, placebo controlled, multicenter phase III study to assess the efficacy and safety of ianalumab in patients with active Sjögren’s syndrome (NEPTUNUS) (Coming Soon)

Other Research Studies

Sjögren’s Team for Accelerating Medicines Partnership (STAMP)

What is the goal of this study?

Our team is using powerful, cutting edge technologies to gain new insight into a variety of autoimmune diseases. The goal of this study is to identify and understand genetic factors that contribute to Sjögren’s disease. This research will provide valuable knowledge about Sjögren’s disease that is likely to facilitate development of better treatments.

Who is conducting the study?

The Sjögren’s Team for Accelerating Medicines Partnership (STAMP) has expertise in rheumatology, oral medicine, ophthalmology, autoimmunity, genetics. The Accelerating Medicines Partnership is a collaboration between government (NIH), private industry, and the Sjögren’s Foundation.

Who is eligible for the study?

  • Individuals who have been diagnosed with Sjögren’s disease
  • Individuals with clinical symptoms strongly suggestive of Sjögren’s disease
  • Individuals who have participated in the Sjögren’s International Collaborative Clinical Alliance (SICCA) study, or in the OMRF Sjögren’s study between 2004 and 2012

What does participation in the Sjögren’s study involve?

  • Complete a health history questionnaire
  • Participate in a half-day clinical evaluation to assess the extent of oral, ocular, and rheumatological manifestations of Sjögren’s disease. This will include measurement of saliva output, collection of saliva, tears, blood, and minor salivary glands from lower lip
  • Authorize researchers to collect medical records of Sjögren’s disease patients that relate to their diagnoses and treatment

How do I become involved?

Reach out to one of our research coordinators:

Susan Robinson
srobin95@jhmi.edu
P: 410-550-6492

Freena Chaudhry, MS
fchaudh4@jhu.edu
P: 410-550-9821

Sjögren’s Syndrome Screening Dry Eye Study (SSDE Study)

  • PI: Dr. Alan Baer
  • Co-Investigator: Dr. Esen Akpek

Sjögren’s syndrome is a systemic autoimmune disorder characterized by lymphocytic infiltration of the salivary and lacrimal glands and other organs along with systemic production of autoantibodies. The involvement of salivary and lacrimal glands leads to progressive decreases in the quantity and quality of saliva and tears and impaired quality of life. Local treatment of the dry eyes and mouth can prevent complications, but does not appear to alter the course of the disease. Early diagnosis and implementation are critical in improving patients’ quality of life and treating complications.

Patients often first present to ophthalmologist with complaints of dry eye, and as a result ophthalmologists are in a unique position to screen patients for possible Sjögren’s syndrome. However, currently there are no evidence-based screening tools for ophthalmologists to use to identify patients with a high likelihood of having Sjögren’s syndrome. The central hypothesis of this research is that using a screening algorithm comprised of a combination of questionnaire responses, autoantibody tests and standard dry eye exam findings will stratify dry eye patients into those having high, medium or low likelihood of having Sjögren’s syndrome.

How do I become involved?

Michael Lin 
Research Assistant for Dr. Esen Akpek
mlin60@jhu.edu
P: 410-522-5214

If you have questions about any of the research being done at the center, please contact:

Susan Robinson
srobin95@jhmi.edu
P: 410-550-6492

Freena Chaudhry, MS
fchaudh4@jhu.edu
P: 410-550-9821

Receive the Latest News from Johns Hopkins Rheumatology

Receive the Latest News from Johns Hopkins Rheumatology

Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.

Interested In

You have Successfully Subscribed!

Use of this Site

All information contained within the Johns Hopkins Jerome L. Green Sjogren’s Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Primary Sidebar

Jerome L. Greene Sjögren’s Syndrome Center Information

  • About Us
  • Meet Our Team
  • Physician Referral Information
  • Schedule An Appointment
  • Contact
  • Directions

Dr. Alan Baer in Chair in Front of Brick Wall Discussing Sjögren’s Syndrome

In this five-part video series on Sjögren’s syndrome, Dr. Alan Baer validates those who suffer from this disease, and informs those who don’t, about the common misconceptions and challenges that Sjögren’s syndrome patients face every day.

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Arthritis Center
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube
U.S. News and World Report Rankings Badge

Johns Hopkins Medicine

© 2023 Johns Hopkins Jerome L. Greene Sjogren's Syndrome Center
Patient Privacy